Cargando…
An update on the development of antiviral against Mayaro virus: from molecules to potential viral targets
Mayaro virus (MAYV), first isolated in 1954 in Trinidad and Tobago islands, is the causative agent of Mayaro fever, a disease characterized by fever, rashes, headaches, myalgia, and arthralgia. The infection can progress to a chronic condition in over 50% of cases, with persistent arthralgia, which...
Autores principales: | Paschoalino, Marina, Marinho, Mikaela dos Santos, Santos, Igor Andrade, Grosche, Victória Riquena, Martins, Daniel Oliveira Silva, Rosa, Rafael Borges, Jardim, Ana Carolina Gomes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990066/ https://www.ncbi.nlm.nih.gov/pubmed/36881172 http://dx.doi.org/10.1007/s00203-023-03441-y |
Ejemplares similares
-
Antivirals Against Chikungunya Virus: Is the Solution in Nature?
por: Oliveira Silva Martins, Daniel, et al.
Publicado: (2020) -
Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020) -
Mayaro Virus: The State-of-the-Art for Antiviral Drug Development
por: Andreolla, Ana Paula, et al.
Publicado: (2022) -
Mayaro: an emerging viral threat?
por: Acosta-Ampudia, Yeny, et al.
Publicado: (2018) -
Mouse Models of Mayaro Virus
por: Rosa, Rafael Borges, et al.
Publicado: (2023)